These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31066988)

  • 41. A prospective randomized study of the effect of a subcutaneously "buried" peritoneal dialysis catheter technique versus standard technique on the incidence of peritonitis and exit-site infection.
    Danielsson A; Blohmé L; Tranaeus A; Hylander B
    Perit Dial Int; 2002; 22(2):211-9. PubMed ID: 11990406
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Do topical antibiotics reduce exit site infection rates and peritonitis episodes in peritoneal dialysis patients? The Pan Thames Renal Audit.
    Davenport A;
    J Nephrol; 2012; 25(5):819-24. PubMed ID: 22241640
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Upward-directed exit-site of the swan-neck catheter and "Easy-to-disinfect the backside area of exit-site" may prevent PD complications.
    Ogawa K; Ikeda M; Shirai I; Ohshiro K; Maruyama Y; Yokoo T; Tanno Y; Terawaki H; Sakurada T; Yoshikawa K; Inoue H; Higuchi C; Kaneko T; Nogaki F; Ueda A; Maeda Y
    Clin Exp Nephrol; 2024 Jun; 28(6):547-556. PubMed ID: 38340245
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of once-a-week vs thrice-a-week application of mupirocin on methicillin and mupirocin resistance in peritoneal dialysis patients: three years of experience.
    Cavdar C; Saglam F; Sifil A; Celik A; Atay T; Gungor O; Ozder A; Gulay Z; Camsari T
    Ren Fail; 2008; 30(4):417-22. PubMed ID: 18569916
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Peritoneal Dialysis Exit-Site Care Protocols in Portugal and Its Association with Catheter-Related Infections.
    Ferreira AC; Fernandes V; Rodrigues A; Abreu CP; Pereira M; Guedes AM; Gomes AM; Cabrita A; Soares C; Pego C; Ferrer F; Bernardo I; Fernandes JC; Assunção J; Oliveira L; Amoedo M; Carvalho MJ; Branco P; Maia P; Chorão R; Castro R; Silva R; Sousa T; Mendes T;
    Blood Purif; 2023; 52(4):366-372. PubMed ID: 36702111
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term peritoneal dialysis experience: quality control supports the use of fluconazole to prevent fungal peritonitis.
    Lopes K; Rocha A; Rodrigues A; Carvalho MJ; Cabrita A
    Int J Artif Organs; 2013 Jul; 36(7):484-8. PubMed ID: 23661559
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Exit-site care in Austrian peritoneal dialysis centers -- a nationwide survey.
    Kopriva-Altfahrt G; König P; Mündle M; Prischl F; Roob JM; Wiesholzer M; Vychytil A; ; Arneitz K; Karner A; Artes R; Wolf E; Auinger M; Pawlak A; Fraberger J; Hofbauer S; Galvan G; Salmhofer H; Pichler B; Wazel M; Gruber M; Thonhofer A; Hager A; Malajner S; Heiss S; Braunsteiner T; Zweiffler M; König P; Rudnicki M; Kogler R; Kohlhauser D; Wiesinger T; Kopriva-Altfahrt G; Moser E; Kotanko P; Loibner H; Nitz H; Miska HJ; Wenzel R; Wölfer M; Mündle M; Breuss H; Hölzl B; Prischi F; Schmekal B; Riener EM; Roob JM; Wonisch W; Vikydal R; Vychytil A; Frank B; Wieser C; Wiesholzer M; Pokorny K
    Perit Dial Int; 2009; 29(3):330-9. PubMed ID: 19458307
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients.
    Bernardini J; Bender F; Florio T; Sloand J; Palmmontalbano L; Fried L; Piraino B
    J Am Soc Nephrol; 2005 Feb; 16(2):539-45. PubMed ID: 15625071
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fungal peritonitis in peritoneal dialysis patients: successful prophylaxis with fluconazole, as demonstrated by prospective randomized control trial.
    Restrepo C; Chacon J; Manjarres G
    Perit Dial Int; 2010; 30(6):619-25. PubMed ID: 20634438
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Decrease in Staphylococcus aureus exit-site infections and peritonitis in CAPD patients by local application of mupirocin ointment at the catheter exit site.
    Thodis E; Bhaskaran S; Pasadakis P; Bargman JM; Vas SI; Oreopoulos DG
    Perit Dial Int; 1998; 18(3):261-70. PubMed ID: 9663889
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Exit-site care and exit-site infection in continuous ambulatory peritoneal dialysis (CAPD): results of a randomized multicenter trial.
    Luzar MA; Brown CB; Balf D; Hill L; Issad B; Monnier B; Moulart J; Sabatier JC; Wauquier JP; Peluso F
    Perit Dial Int; 1990; 10(1):25-9. PubMed ID: 2085577
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of preventing Staphylococcus aureus carriage on rates of peritoneal catheter-related staphylococcal infections. Literature synthesis.
    Ritzau J; Hoffman RM; Tzamaloukas AH
    Perit Dial Int; 2001; 21(5):471-9. PubMed ID: 11757831
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antimicrobial agents to prevent peritonitis in peritoneal dialysis: a systematic review of randomized controlled trials.
    Strippoli GF; Tong A; Johnson D; Schena FP; Craig JC
    Am J Kidney Dis; 2004 Oct; 44(4):591-603. PubMed ID: 15384009
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chlorhexidine for routine PD catheter exit-site care.
    Olga B; Fotis Z; Margarita I; Sofia X; Konstantinos S
    Int Urol Nephrol; 2016 Sep; 48(9):1543-6. PubMed ID: 27432412
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical outcomes in peritoneal dialysis: impact of continuous quality provement initiatives.
    Qamar M; Sheth H; Bender FH; Piraino B
    Adv Perit Dial; 2009; 25():76-9. PubMed ID: 19886322
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Catheter type, placement and insertion techniques for preventing peritonitis in peritoneal dialysis patients.
    Strippoli GF; Tong A; Johnson D; Schena FP; Craig JC
    Cochrane Database Syst Rev; 2004 Oct; (4):CD004680. PubMed ID: 15495125
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Extended Swan-Neck Catheter With Upper Abdominal Exit-Site Reduces Peritoneal Dialysis-Related Infections.
    Eriguchi M; Tsuruya K; Yoshida H; Haruyama N; Tanaka S; Tsuchimoto A; Fujisaki K; Torisu K; Masutani K; Kitazono T
    Ther Apher Dial; 2016 Apr; 20(2):158-64. PubMed ID: 26762798
    [TBL] [Abstract][Full Text] [Related]  

  • 58. ISPD guideline-driven retraining, exit site care and decreased peritonitis: a single-center experience in Israel.
    Einbinder Y; Cohen-Hagai K; Shitrit P; Zitman-Gal T; Erez D; Benchetrit S; Korzets Z; Kotliroff A
    Int Urol Nephrol; 2019 Apr; 51(4):723-727. PubMed ID: 30834483
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Amuchina 10% solution, safe antiseptic for preventing infections of exit-site of Tenckhoff catheters, in the pediatric population of a dialysis program.
    Mendoza-Guevara L; Castro-Vazquez F; Aguilar-Kitsu A; Morales-Nava A; Rodriguez-Leyva F; Sanchez-Barbosa JL
    Contrib Nephrol; 2007; 154():139-144. PubMed ID: 17099309
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prophylaxis against gram-positive organisms causing exit-site infection and peritonitis in continuous ambulatory peritoneal dialysis patients by applying mupirocin ointment at the catheter exit site.
    Wong SS; Chu KH; Cheuk A; Tsang WK; Fung SK; Chan HW; Tong MK
    Perit Dial Int; 2003 Dec; 23 Suppl 2():S153-8. PubMed ID: 17986538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.